Literature DB >> 23436247

A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.

Yatendra Kumar Satija1, Abhishek Bhardwaj, Sanjeev Das.   

Abstract

E3 ubiquitin ligases and deubiquitylating enzymes (DUBs) are the key components of ubiquitin proteasome system which plays a critical role in cellular protein homeostasis. Any shortcoming in their biological roles can lead to various diseases including cancer. The dynamic interplay between ubiquitylation and deubiquitylation determines the level and activity of several proteins including p53, which is crucial for cellular stress response and tumor suppression pathways. In this review, we describe the different types of E3 ubiquitin ligases including those targeting tumor suppressor p53, SCF ligases and RING type ligases and accentuate on biological functions of few important E3 ligases in the cellular regulatory networks. Tumor suppressor p53 level is tightly regulated by multiple E3 ligases including Mdm2, COP1, Pirh2, etc. SCF ubiquitin ligase complexes are key regulators of cell cycle and signal transduction. BRCA1 and VHL RING type ligases function as tumor suppressors and play an important role in DNA repair and hypoxia response respectively. Further, we discuss the biological consequences of deregulation of the E3 ligases and the implications for cancer development. We also describe deubiquitylases which reverse the process of ubiquitylation and regulate diverse cellular pathways including metabolism, cell cycle control and chromatin remodelling. As the E3 ubiquitin ligases and DUBs work in a substrate specific manner, an improved understanding of them can lead to better therapeutics for cancer.
Copyright © 2013 UICC.

Entities:  

Keywords:  cancer; p53; proteasome; ubiquitylation

Mesh:

Substances:

Year:  2013        PMID: 23436247     DOI: 10.1002/ijc.28129

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Dynamic ubiquitination of the mitogen-activated protein kinase kinase (MAPKK) Ste7 determines mitogen-activated protein kinase (MAPK) specificity.

Authors:  Jillian H Hurst; Henrik G Dohlman
Journal:  J Biol Chem       Date:  2013-05-03       Impact factor: 5.157

Review 2.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

3.  Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.

Authors:  Jeanne E McKeon; Di Sha; Lian Li; Lih-Shen Chin
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

Review 4.  Functional roles of E3 ubiquitin ligases in prostate cancer.

Authors:  Yiting Zhao; Jinyun Li; Jun Chen; Meng Ye; Xiaofeng Jin
Journal:  J Mol Med (Berl)       Date:  2022-07-11       Impact factor: 5.606

5.  Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation.

Authors:  Noa Rivlin; Shir Katz; Maayan Doody; Michal Sheffer; Stav Horesh; Alina Molchadsky; Gabriela Koifman; Yoav Shetzer; Naomi Goldfinger; Varda Rotter; Tamar Geiger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

6.  Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity.

Authors:  Aslamuzzaman Kazi; Sevil Ozcan; Awet Tecleab; Ying Sun; Harshani R Lawrence; Saïd M Sebti
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

7.  UBE2S is associated with malignant characteristics of breast cancer cells.

Authors:  Akter Khondker Ayesha; Toshinori Hyodo; Eri Asano; Naoki Sato; Mohammed A Mansour; Satoko Ito; Michinari Hamaguchi; Takeshi Senga
Journal:  Tumour Biol       Date:  2015-08-06

Review 8.  The role of the ubiquitin proteasome system in cerebellar development and medulloblastoma.

Authors:  Jerry Vriend; Saeid Ghavami; Hassan Marzban
Journal:  Mol Brain       Date:  2015-10-17       Impact factor: 4.041

9.  WWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits the AKT signaling and tumor growth in mice.

Authors:  Chonji Fukumoto; Dai Nakashima; Atsushi Kasamatsu; Motoharu Unozawa; Tomomi Shida-Sakazume; Morihiro Higo; Katsunori Ogawara; Hidetaka Yokoe; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  Oncoscience       Date:  2014-11-28

10.  SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice.

Authors:  Salvatore Delogu; Chunmei Wang; Antonio Cigliano; Kirsten Utpatel; Marcella Sini; Thomas Longerich; Nina Waldburger; Kai Breuhahn; Lijie Jiang; Silvia Ribback; Frank Dombrowski; Matthias Evert; Xin Chen; Diego F Calvisi
Journal:  Oncotarget       Date:  2015-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.